December 20, 2022
Webinar
New Jersey Intellectual Property Law Association (NJIPLA)
Finnegan partner David Weingarten will join a panel discussion on the patentability of chemical and pharmaceutical inventions at the New Jersey Intellectual Property Law Association’s webinar. Discussion content will also cover novelty, obviousness, sufficiency of disclosure, as well as differences between the U.S. and Europe. For more information, or to register, please see NJIPLA’s website.
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Articles
Unpacking Squires’ Recent Discretionary Denial Guidance Focusing on American Manufacturing
April 24, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.